Zolotaikina MarharytaFedorytenko RomanKurmanska LarysaKirkilevska Liudmila2024-10-302024-10-302024-07-29Zolotaikina , M., Fedorytenko , R., Kurmanska , L., & Kirkilevska , L. (2024). IMPACT OF PHARMACOGENOMICS ON PHARMACOKINETIC OF BETA BLOCKERS. Collection of Scientific Papers «ΛΌГOΣ», (July 19, 2024; Boston, USA), 275–276. https://doi.org/10.36074/logos-19.07.2024.054978-617-8312-06-010.36074/logos-19.07.2024.054https://ir.kmu.edu.ua/handle/123456789/270Beta adrenergic blockers (β‐blockers) antagonize beta-1, beta-2 adrenergic receptors, and have been widely used for cardiovascular therapy, as well as treatment of disorders such as anxiety, thyrotoxicosis and glaucoma.enBeta adrenergic blockerscardiovascular therapytreatmentThesis